多发性硬化症免疫抑制治疗的临床实践：第二次国际问卷调查结果
Clinical practice of immunosuppressive treatments in multiple sclerosis: results of a second international questionnaire.
作者信息
Hommes O R, Weiner H L
机构信息
European Charcot Foundation, 6533 PA Nijmegen, The Netherlands.
出版信息
J Neurol Sci. 2004 Aug 15;223(1):65-7. doi: 10.1016/j.jns.2004.04.022.
PMID:15261563
Abstract
Immunosuppressive treatment is a current practice in MS therapy. Mitoxantrone has gained largest acceptance. Differences in clinical indications of mitoxantrone, cyclophosphamide, azathioprine and methotrexate are described.
摘要
免疫抑制治疗是目前多发性硬化症治疗中的一种常用方法。米托蒽醌已获得了最广泛的认可。文中描述了米托蒽醌、环磷酰胺、硫唑嘌呤和甲氨蝶呤在临床适应症方面的差异。
Zotero 插件